| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $766.9M | +39.2% |
| Cost of Revenue | $165.3M | +41.9% |
| Gross Profit | $601.6M | +38.5% |
| R&D Expense | $215.2M | +30.1% |
| SG&A Expense | $128.8M | +18.0% |
| Operating Income | -$221.6M | -30.3% |
| Pre-tax Income | -$212.8M | -24.6% |
| Income Tax | $2.8M | +862.5% |
| Net Income | -$215.6M | -26.0% |
| EPS (Basic) | -$1.66 | -22.1% |
| EPS (Diluted) | -$1.66 | -22.1% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $223.2M | -50.3% |
| Short-term Investments | $233.2M | — |
| Accounts Receivable | $198.6M | +31.4% |
| Current Assets | $710.1M | +11.9% |
| Total Assets | $1.11B | +10.7% |
| Current Liabilities | $574.7M | +31.4% |
| Total Liabilities | $624.6M | +25.4% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $23.6M | +771.6% |
| Capital Expenditures | $6.1M | -41.9% |
| Investing Cash Flow | -$263.9M | -1342.1% |
| Financing Cash Flow | $14.1M | -53.7% |
| Free Cash Flow | $17.5M | +224.0% |
| Stockholders' Equity |
| $485.7M |
| -3.8% |